DISEASE INDICATIONS: Primary Biliary Cholangitis (PBC)

MANUFACTURER: Intercept Pharma Ltd

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Therapeutic Goods Administration (TGA)

Ocaliva is used primarily for treating PBC by binding to the nuclear receptor FXR, modulating liver function and reducing PBC symptoms.